3Cochlear Implantation and Tinnitus Suppression

FFrom deafferentation to central gain

The dominant model of tinnitus in profound deafness is deafferentation. When the cochlea stops feeding the central auditory pathway, the brain compensates by turning up its own gain; this central hyperactivity and the cortical reorganisation that accompanies it are heard as phantom sound. The logic is therefore simple: if loss of input drove the gain up, restoring input should bring it back down.

A cochlear implant does exactly that, bypassing the dead hair cells to stimulate the auditory nerve directly. By re-establishing patterned afferent activity, it can re-normalise central excitability and, in many recipients, reduce or abolish the tinnitus that the deafness produced [2013].

TThree overlapping mechanisms

Suppression is not explained by a single process. First, and most important, is the reversal of deafferentation: re-feeding the auditory system lowers the maladaptive central gain. Second is a masking effect, in which the electrical stimulation during device use directly competes with or overrides the tinnitus percept. Third is reorganisation, as restored input remodels the tonotopic maps that distorted during deafness.

These mechanisms interact and their relative weight differs between patients, which is part of why outcomes vary. Some patients describe relief that persists even when the processor is switched off — consistent with durable central change — while others find the tinnitus returns without active stimulation, pointing more to ongoing masking [2015].

CThe evidence and its variability

Systematic reviews of cochlear implantation in deaf patients report that a large share experience tinnitus reduction. Across studies, reported suppression spans roughly a quarter to two-thirds or more of recipients, with full suppression in a smaller subset; the wide range reflects heterogeneous populations, outcome measures, and follow-up [2015]. A review of unilateral and bilateral implantation found that, overall, more patients improve than worsen, though a small minority report new or aggravated tinnitus after surgery [2016].

Because the indication for implantation is severe-to-profound deafness, this evidence is best read as: in patients who already qualify for an implant on hearing grounds, coexisting tinnitus is likely — though not certain — to improve as a bonus. It does not establish cochlear implantation as a standalone tinnitus operation for hearing ears.

CCounselling: tinnitus as a secondary benefit

The clinical framing matters. A patient being implanted for deafness should be told that tinnitus often improves, sometimes markedly, but that the response is variable, may depend on regular device use, and that a small number of patients notice no change or transient worsening, especially early after activation.

Timing may matter too: earlier restoration of input, before central reorganisation entrenches, is thought to favour better tinnitus outcomes, which is one argument for not delaying implantation in eligible deaf ears. Within a stepped, multidisciplinary pathway, tinnitus suppression is presented as a probable secondary benefit of hearing restoration rather than the primary surgical aim [2019].